Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. / Frederiksen, Birgitte Lidegaard; Brown, Peter de Nully; Dalton, Susanne Oksbjerg; Steding-Jessen, Marianne; Osler, Merete.

I: European journal of cancer (Oxford, England : 1990), Bind 47, Nr. 6, 01.04.2011, s. 910-7.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Frederiksen, BL, Brown, PDN, Dalton, SO, Steding-Jessen, M & Osler, M 2011, 'Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database', European journal of cancer (Oxford, England : 1990), bind 47, nr. 6, s. 910-7. https://doi.org/10.1016/j.ejca.2010.11.014

APA

Frederiksen, B. L., Brown, P. D. N., Dalton, S. O., Steding-Jessen, M., & Osler, M. (2011). Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. European journal of cancer (Oxford, England : 1990), 47(6), 910-7. https://doi.org/10.1016/j.ejca.2010.11.014

Vancouver

Frederiksen BL, Brown PDN, Dalton SO, Steding-Jessen M, Osler M. Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. European journal of cancer (Oxford, England : 1990). 2011 apr 1;47(6):910-7. https://doi.org/10.1016/j.ejca.2010.11.014

Author

Frederiksen, Birgitte Lidegaard ; Brown, Peter de Nully ; Dalton, Susanne Oksbjerg ; Steding-Jessen, Marianne ; Osler, Merete. / Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. I: European journal of cancer (Oxford, England : 1990). 2011 ; Bind 47, Nr. 6. s. 910-7.

Bibtex

@article{21cc78b771e945058839c07f50f28a3a,
title = "Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database",
abstract = "The survival of non-Hodgkin lymphoma patients strongly depends on a range of prognostic factors. This registry-based clinical cohort study investigates the relation between socioeconomic position and prognostic markers in 6234 persons included in a national clinical database in 2000-2008, Denmark. Several measures of individual socioeconomic position were achieved from Statistics Denmark. The risk of being diagnosed with advanced disease, as expressed by the six prognostic markers (Ann Arbor stage III or IV, more than one extranodal lesion, elevated serum lactate dehydrogenase (LDH), performance status of two or more, presence of B symptoms and International Prognostic Index (IPI) of two or more), increased with decreasing level of education, in patients living alone, and in men. For instance, a significant decrease in the odds of being diagnosed with elevated LDH (p=0.02), high performance status (p=0.004), high IPI score (p=0.004) and B symptoms (p=0.02) was seen with higher level of education, whereas high stage of disease was significantly less likely in the higher educated (odds ratio [OR]=0.85 (0.74-0.99)). The difference in risk seemed not to be mediated by differences in histological subgroups reflecting aggressiveness of disease among the social groups. One of the most likely mechanisms of the social difference is longer delay in those with low socioeconomic position. The findings of social inequality in prognostic markers in non-Hodgkin lymphoma (NHL) patients could already be implemented in the clinical practice if general practitioners (GP's) and physicians on hospitals paid special attention to patients with low educational level and unspecific symptoms.",
author = "Frederiksen, {Birgitte Lidegaard} and Brown, {Peter de Nully} and Dalton, {Susanne Oksbjerg} and Marianne Steding-Jessen and Merete Osler",
note = "Copyright {\circledC} 2010 Elsevier Ltd. All rights reserved.",
year = "2011",
month = "4",
day = "1",
doi = "10.1016/j.ejca.2010.11.014",
language = "English",
volume = "47",
pages = "910--7",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Pergamon",
number = "6",

}

RIS

TY - JOUR

T1 - Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database

AU - Frederiksen, Birgitte Lidegaard

AU - Brown, Peter de Nully

AU - Dalton, Susanne Oksbjerg

AU - Steding-Jessen, Marianne

AU - Osler, Merete

N1 - Copyright © 2010 Elsevier Ltd. All rights reserved.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - The survival of non-Hodgkin lymphoma patients strongly depends on a range of prognostic factors. This registry-based clinical cohort study investigates the relation between socioeconomic position and prognostic markers in 6234 persons included in a national clinical database in 2000-2008, Denmark. Several measures of individual socioeconomic position were achieved from Statistics Denmark. The risk of being diagnosed with advanced disease, as expressed by the six prognostic markers (Ann Arbor stage III or IV, more than one extranodal lesion, elevated serum lactate dehydrogenase (LDH), performance status of two or more, presence of B symptoms and International Prognostic Index (IPI) of two or more), increased with decreasing level of education, in patients living alone, and in men. For instance, a significant decrease in the odds of being diagnosed with elevated LDH (p=0.02), high performance status (p=0.004), high IPI score (p=0.004) and B symptoms (p=0.02) was seen with higher level of education, whereas high stage of disease was significantly less likely in the higher educated (odds ratio [OR]=0.85 (0.74-0.99)). The difference in risk seemed not to be mediated by differences in histological subgroups reflecting aggressiveness of disease among the social groups. One of the most likely mechanisms of the social difference is longer delay in those with low socioeconomic position. The findings of social inequality in prognostic markers in non-Hodgkin lymphoma (NHL) patients could already be implemented in the clinical practice if general practitioners (GP's) and physicians on hospitals paid special attention to patients with low educational level and unspecific symptoms.

AB - The survival of non-Hodgkin lymphoma patients strongly depends on a range of prognostic factors. This registry-based clinical cohort study investigates the relation between socioeconomic position and prognostic markers in 6234 persons included in a national clinical database in 2000-2008, Denmark. Several measures of individual socioeconomic position were achieved from Statistics Denmark. The risk of being diagnosed with advanced disease, as expressed by the six prognostic markers (Ann Arbor stage III or IV, more than one extranodal lesion, elevated serum lactate dehydrogenase (LDH), performance status of two or more, presence of B symptoms and International Prognostic Index (IPI) of two or more), increased with decreasing level of education, in patients living alone, and in men. For instance, a significant decrease in the odds of being diagnosed with elevated LDH (p=0.02), high performance status (p=0.004), high IPI score (p=0.004) and B symptoms (p=0.02) was seen with higher level of education, whereas high stage of disease was significantly less likely in the higher educated (odds ratio [OR]=0.85 (0.74-0.99)). The difference in risk seemed not to be mediated by differences in histological subgroups reflecting aggressiveness of disease among the social groups. One of the most likely mechanisms of the social difference is longer delay in those with low socioeconomic position. The findings of social inequality in prognostic markers in non-Hodgkin lymphoma (NHL) patients could already be implemented in the clinical practice if general practitioners (GP's) and physicians on hospitals paid special attention to patients with low educational level and unspecific symptoms.

U2 - 10.1016/j.ejca.2010.11.014

DO - 10.1016/j.ejca.2010.11.014

M3 - Journal article

C2 - 21145729

VL - 47

SP - 910

EP - 917

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 6

ER -

ID: 34236240